Originally Posted by
nextbigthing
1 million cases of Haematuria in the US each year.
Population of the States approx 317 million.
Therefore 1/317x100 = 0.315% of the population with Haematuria.
PEB has 40m + 14m + 8m covered = 62 million
62000000 x 0.315% = 195300 cases of Haematuria that will have PEB coverage
If 10%, ie 1 in 10 of these people decided peeing in to a cup was better than having a camera up the whowho and only got tested once (unlikely) then that would equate to 19530 tests P.A. at this early stage. That's 19530 cards sent to Doctors thanking them for not having the camera and 19530 people having a whiskey telling their mates that CXBladder is the way to go.
At $500 a test x 19530 that's almost $10000000 revenue. Again not bad IMHO at this early stage.
Also, it was only two days between announcing they had the FedMed agreement and annoucing the first commercial sales.
This suggests someone was definitely keen to use it and that's a very good sign as the PEB marketers must be doing their job. It also suggests at least some Urologists are open to change - the rest will be forced to change as the whiskey drinkers demand it when their turn comes around.
Management holding onto very large interests with no recent selling is also a positive.
Perhaps some are being a bit harsh on PEB and will be presently surprised (or disappointed when they have to buy back in at $2).
DYOR.
NBT
Disc Hold.